| Literature DB >> 32694520 |
Anupam Dhasmana1,2, Swati Uniyal3, Vivek Kumar Kashyap1, Pallavi Somvanshi4, Meenu Gupta2, Uma Bhardwaj2, Meena Jaggi1, Murali M Yallapu1, Shafiul Haque5, Subhash C Chauhan6.
Abstract
Curcumin is an important bioactive component of turmeric and also one of the important natural products, which has been investigated extensively. The precise mode of action of curcumin and its impact on system level protein networks are still not well studied. To identify the curcumin governed regulatory action on protein interaction network (PIN), an interectome was created based on 788 key proteins, extracted from PubMed literatures, and constructed by using STRING and Cytoscape programs. The PIN rewired by curcumin was a scale-free, extremely linked biological system. MCODE plug-in was used for sub-modulization analysis, wherein we identified 25 modules; ClueGo plug-in was used for the pathway's enrichment analysis, wherein 37 enriched signalling pathways were obtained. Most of them were associated with human diseases groups, particularly carcinogenesis, inflammation, and infectious diseases. Finally, the analysis of topological characteristic like bottleneck, degree, GO term/pathways analysis, bio-kinetics simulation, molecular docking, and dynamics studies were performed for the selection of key regulatory proteins of curcumin-rewired PIN. The current findings deduce a precise molecular mechanism that curcumin might exert in the system. This comprehensive in-silico study will help to understand how curcumin induces its anti-cancerous, anti-inflammatory, and anti-microbial effects in the human body.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32694520 PMCID: PMC7374742 DOI: 10.1038/s41598-020-69011-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Classification of 62 enriched KEGG pathways for human diseases obtained during the PPI of curcumin associated proteins list of pathways was generated by STRING.
Figure 2Node degree distribution. A power law of the form y = 258.52x − 1.171 was fitted (R-squared = 0.715) Graph generated by Cytoscape plugin Network Analyzer.
Figure 3Characteristics Path length distribution is 3.188. Graph generated by Cytoscape plugin Network Analyzer.
Figure 4Clustering coefficient distribution is 0.472. Graph generated by Cytoscape plugin Network Analyzer.
Figure 5Final selected PIN of modulated seed proteins and connector proteins (Figure generated from Cytoscape) obtained from STRING.
10 best bottle neck scores of seed and connector proteins. The selection was done on the basis of higher bottle neck score and clustering coefficient (less than 0.5, these proteins were considered as a date hub proteins).
| S. No | Name | Bottle neck | Betweenness | Closeness | Clustering coefficient | Degree |
|---|---|---|---|---|---|---|
| 1 | CREBBP | 52 | 13,223.35 | 155.8333 | 0.15837 | 50 |
| 2 | TP53 | 22 | 7,640.317 | 148.4167 | 0.17639 | 38 |
| 3 | RELA | 14 | 4,458.032 | 149.0833 | 0.20863 | 51 |
| 4 | MAPK1 | 13 | 4,779.75 | 146.5 | 0.18316 | 47 |
| 5 | NFKB1 | 11 | 3,211.738 | 144.8333 | 0.22304 | 44 |
| 6 | CYP1A1 | 10 | 4,831.488 | 110.8667 | 0.43137 | 18 |
| 7 | SRC | 9 | 2,899.138 | 135.6667 | 0.17424 | 33 |
| BRCA1 | 9 | 1537.711 | 128.1 | 0.38413 | 36 | |
| EDN1 | 9 | 684.0157 | 123.8333 | 0.29412 | 18 | |
| ATR | 9 | 647.5952 | 124.0667 | 0.38391 | 30 | |
| 8 | RB1 | 7 | 2,625.42 | 142.8333 | 0.29445 | 38 |
| SP1 | 7 | 391.5314 | 130.6667 | 0.34762 | 21 | |
| 9 | CASP8 | 6 | 2,299.261 | 123.3667 | 0.4152 | 19 |
| STAT1 | 6 | 1,012.291 | 130.1667 | 0.36594 | 24 | |
| CREB1 | 6 | 597.4255 | 121.6667 | 0.30882 | 17 | |
| 10 | AKT1 | 5 | 2,328.794 | 137.4167 | 0.17094 | 27 |
| IL8 | 5 | 2,227.319 | 121.1667 | 0.4058 | 24 | |
| CDH1 | 5 | 1,162.138 | 113 | 0.34848 | 12 | |
| KRAS | 5 | 917.6512 | 120.8333 | 0.25692 | 23 | |
| SYK | 5 | 796.2624 | 123.6667 | 0.24265 | 17 | |
| CCR5 | 5 | 669.6932 | 108.3667 | 0.42222 | 10 | |
| HDAC3 | 5 | 471.1578 | 124.3333 | 0.35263 | 20 |
Figure 6ClueGO results of GO functional enrichment of key proteins.
GO functional group analysis with their associated genes (data generated by ClueGO plugin).
| GOID | GO term | GO groups | Associated genes found |
|---|---|---|---|
| KEGG:04137 | Mitophagy | Group00 | [KRAS, RELA, SP1, SRC, TP53] |
| R-HSA:10906 | Intrinsic pathway for apoptosis | Group01 | [AKT1, CASP8, TP53] |
| KEGG:05167 | Kaposi's sarcoma-associated herpes virus infection | Group02 | [AKT1, CASP8, CCR5, CREB1, CREBBP, CXCL8, KRAS, MAPK1, NFKB1, RB1, RELA, SRC, STAT1, SYK, TP53] |
| KEGG:04210 | Apoptosis | Group03 | [AKT1, CASP8, KRAS, MAPK1, NFKB1, RELA, TP53] |
| KEGG:04926 | Relaxin signalling pathway | Group04 | [AKT1, CREB1, EDN1, KRAS, MAPK1, NFKB1, RELA, SRC] |
| KEGG:05161 | Hepatitis B | Group05 | [AKT1, CASP8, CREB1, CREBBP, CXCL8, KRAS, MAPK1, NFKB1, RB1, RELA, SRC, STAT1, TP53] |
| KEGG:05218 | Melanoma | Group06 | [AKT1, CDH1, KRAS, MAPK1, RB1, TP53] |
| KEGG:04919 | Thyroid hormone signalling pathway | Group07 | [AKT1, CREBBP, HDAC3, KRAS, MAPK1, SRC, STAT1, TP53] |
| R-HSA:8940973 | RUNX2 regulates osteoblast differentiation | Group08 | [HDAC3, MAPK1, RB1, SRC] |
| KEGG:05203 | Viral carcinogenesis | Group09 | [CASP8, CCR5, CREB1, CREBBP, HDAC3, KRAS, MAPK1, NFKB1, RB1, RELA, SRC, SYK, TP53] |
| KEGG:04066 | HIF-1 signalling pathway | Group10 | [AKT1, CREBBP, EDN1, MAPK1, NFKB1, RELA] |
| KEGG:05165 | Human papilloma virus infection | Group11 | [AKT1, ATR, CASP8, CREB1, CREBBP, HDAC3, KRAS, MAPK1, NFKB1, RB1, RELA, STAT1, TP53] |
| KEGG:05212 | Pancreatic cancer | Group12 | [AKT1, KRAS, MAPK1, NFKB1, RB1, RELA, STAT1, TP53] |
| R-HSA:8878166 | Transcriptional regulation by RUNX2 | Group13 | [AKT1, HDAC3, MAPK1, RB1, SRC, STAT1] |
| KEGG:05215 | Prostate cancer | Group14 | [AKT1, CREB1, CREBBP, KRAS, MAPK1, NFKB1, RB1, RELA, TP53] |
| KEGG:04062 | Chemokine signalling pathway | Group15 | [AKT1, CCR5, CXCL8, KRAS, MAPK1, NFKB1, RELA, SRC, STAT1] |
| KEGG:05152 | Tuberculosis | Group16 | [AKT1, CASP8, CREB1, CREBBP, MAPK1, NFKB1, RELA, SRC, STAT1, SYK] |
Figure 7(A) Backbone RMSD of curcumin bound MAPK1 during 50000 ps molecular dynamics trajectory; (B) Per residue fluctuations of curcumin bound MAPK1 during 50000 ps molecular dynamics; (C) Pre-MD interactions of curcumin with MAPK1; (D) Post-MD interactions of curcumin with MAPK1.
Figure 8Demonstrate the MAPK cascade and the inhibition of MAPK1/Erk2 by curcumin.
Figure 9Bio-kinetic simulation of MAPK cascade in normal condition.
Figure 10Bio-kinetic simulation of inhibitory impact of curcumin on MAPK cascade.
Figure 11Graphical representation of curcumin's impact on systems level proteins interaction network with their respective key proteins, number of associated and enriched pathways.